2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.Advanced Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 32026-01-22NCT07284134
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung CancerC-Met Exon 14 MutationRecruitingPhase 1 / Phase 22022-08-01NCT04270591